The company's drug repositioning platform evaluates compounds for multiple therapeutic areas, advancing them through internal drug development or with a strategic partner. Melior Pharmaceuticals aims to discover new uses for existing drugs, which have already been proven safe for human use, to reduce the cost and time associated with developing new drugs from scratch. By leveraging its expertise in drug repositioning, Melior Pharmaceuticals is poised to make a significant impact in the pharmaceutical industry by bringing new treatments to market more efficiently and effectively.